“Efficacy of Deucravacitinib over time in Psoriasis by Baseline Total Body Surface Area: Post Hoc Analysis of the Randomized, Double-blind, Placebo-controlled Phase 3b/4 PSORIATYK SCALP Trial”, J of Skin, vol. 9, no. 2, p. s537, Mar. 2025, doi: 10.25251/skin.10.supp.537.